Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for prevention of radiotherapy-induced skin toxicity in breast cancer
IRCT2014100619423N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Apr 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of celecoxib in radiodermatitis, sponsored by Mazandaran University of Medical Sciences. Started Apr 2015; status: completed.
02
Drugs
celecoxib
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on IRCT2014100619423N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014100619423N1.